2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lung Neoplasms
23
Breast Neoplasms
11
Prostatic Neoplasms
10
Stomach Neoplasms
7
Carcinoma, Hepatocellular
6
Small Cell Lung Carcinoma
4
Melanoma
4
Lymphoma
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Pulmonary Nodules
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Disease
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Smoking Cessation
2
Smoking
2
Sarcopenia
2
Recurrence
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Cyclophosphamide
45
Prednisone
31
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
29
Vincristine
28
Doxorubicin
27
Etoposide
22
romidepsin
20
Gemcitabine
18
Lenalidomide
16
10-propargyl-10-deazaaminopterin
16
fludarabine phosphate
15
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
14
Brentuximab Vedotin
14
Azacitidine
13
Mycophenolic Acid
12
Dexamethasone
10
Cyclosporine
10
Bortezomib
10
Alemtuzumab
10
Rituximab
8
fludarabine
7
belinostat
7
Methotrexate
6
Cytarabine
6
Busulfan
6
Bendamustine Hydrochloride
6
pembrolizumab
5
denileukin diftitox
5
Nivolumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Tomography, X-Ray Computed
×
Clear all
NCT06362148
2026-05-01
CIRCULATE
University of Aarhus
Active not recruiting
50 enrolled